Artiva Biotherapeutics Inc (ARTV)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ARTV market cap is 255.77M. The company's latest EPS is USD -1.1824 and P/E is -9.16.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD ($) | |||
| Total Revenue | 251k | 0 | 0 |
| Operating Income | -14.49M | -16.19M | -18.33M |
| Net Income | -13.96M | -17.84M | -17.47M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 33.49M |
| Operating Income | -30.67M |
| Net Income | -28.72M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD ($) | |||
| Total Assets | 90.16M | 75.91M | 225.6M |
| Total Liabilities | 48.42M | 50.6M | 24.6M |
| Total Equity | -174.67M | -191.1M | 201M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Assets | 105.11M |
| Total Liabilities | 50.72M |
| Total Equity | -162.02M |
| Market Cap | 255.77M |
| Price to Earnings Ratio | -9.16 |
| Price to Sales Ratio | 7.85 |
| Price to Cash Ratio | 4.92 |
| Price to Book Ratio | 4.84 |
| Dividend Yield | - |
| Shares Outstanding | 24.29M |
| Average Volume (1 week) | 50.93k |
| Average Volume (1 Month) | 65.72k |
| 52 Week Change | -34.19% |
| 52 Week High | 17.31 |
| 52 Week Low | 9.68 |
| Spread (Intraday) | 1.55 (13.6%) |
| Company Name | Artiva Biotherapeutics Inc |
| Address |
838 walker rd, suite 21-2 dover, delaware 19904 |
| Website | https://www.artivabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
